Story thread · 2 reports / 2 sources

Bicara Therapeutics announces CEO transition, CFO appointment

investing.com · 10h · first report

The coverage

Bicara outlines mid-2027 interim analysis timeline as it initiates FORTIFI-FLEX and names a new CEO and CFO
seekingalpha.com · 6h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.